Epidemiological profile of patients treated in a public service with Breast Cancer in Brasilia
DOI:
https://doi.org/10.51723/hrj.v5i25.1002Keywords:
Breast neoplasms, Screening, Health profile, Public HealthAbstract
Introduction: Breast cancer is the most diagnosed malignancy in the world. With particularities related to age and staging, Brasilian women are at greater risk of being diagnosed with an advanced disease. The Ministry of Health of Brasil usually recommends screening for the age group from 50 to 69 years old, with the aim of detecting early stages of the disease. It is important to correlate local numbers with screening efforts and age at diagnosis. Endpoints: Correlate age at diagnosis with literature data, histological subtypes and epidemiological profile of patients treated. Methods: Cross-sectional, analytical, retrospective study through analysis of medical records of patients with breast cancer treated in a public hospital in Brasília between 2015 and 2019. Results: 782 medical records were evaluated. Age ranged from 27 to 86 years, with 40% under 50 and 60% aged 50 or over. The most common stages were II and III (35% each). 37% were variants with a poor prognosis (triple negative and HER2+ diseases) while 62% were with a variable prognosis (luminal disease). 30% underwent adjuvant treatment, 26% neoadjuvant treatment and 7% palliative treatment. Conclusion: The study was consistent with the literature. The screening policy must be a priority in the Federal District.
References
- Instituto Nacional do Câncer - INCA. Definição do câncer de mama e dados de incidência e mortalidade no Brasil. Conceito e Magnitude. Publicado em 16/09/2022. Disponível em: https://www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controle-do-cancer-de-mama/conceito-e-magnitude. Acesso em: abril de 2023.
- “GLOBOCAN 2020: New Global Cancer Data | UICC.” www.uicc.org, 2020, www.uicc.org/news/globocan-2020-new-global-cancer-data. Acesso em: abril de 2023.
- Simon SD et al. “Characteristics and Prognosis of Stage I-III Breast Cancer Subtypes in Brazil: The AMAZONA Retrospective Cohort Study.” The Breast, vol. 44, Apr. 2019, pp. 113–119, https://doi.org/10.1016/j.breast.2019.01.008.
- Rosa DD et al. “The Impact of Sociodemographic Factors and Health Insurance Coverage in the Diagnosis and Clinicopathological Characteristics of Breast Cancer in Brazil: AMAZONA III Study (GBECAM 0115).” Breast Cancer Research and Treatment, vol. 183, no. 3, 29 July 2020, pp. 749–757, https://doi.org/10.1007/s10549-020-05831-y.
- Lei S et al. “Global Patterns of Breast Cancer Incidence and Mortality: A Population‐Based Cancer Registry Data Analysis from 2000 to 2020.” Cancer Communications, vol. 41, no. 11, 16 Aug. 2021, https://doi.org/10.1002/cac2.12207.
- Instituto Nacional do Câncer - INCA. Atlas Online de Mortalidade. Taxas de mortalidade por cancer, brutas e ajustadas por idade pelas populações mundial e brasileira, por 100.000, segundo sexo, faixa etária, localidade e por período selecionado. Disponível em: https://www.inca.gov.br/MortalidadeWeb/pages/Modelo03/consultar.xhtml#panelResultado. Acesso em: novembro de 2023.
- American Joint Committee on Cancer (AJCC). Cancer Staging Manual; 8th edition, 3rd printing, Amin MB, Edge SB, Greene FL, et al (Eds), Springer, Chicago 2018.
- Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: incidência do Câncer no Brasil. Rio de Janeiro: INCA, 2022. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/numeros/estimativa Acesso em: 25 nov 2022.
- MS/INCA/Conprev/DIVAS Integrador RHC. Disponível em: https://www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controle-do-cancer-de-mama/dados-e-numeros/estadiamento. Acesso em: novembro de 2023.
- Dutra MC et al. “Imunofenótipo E Evolução de Câncer de Mama: Comparação Entre Mulheres Muito Jovens E Mulheres Na Pós-Menopausa.” Revista Brasileira de Ginecologia E Obstetrícia, vol. 31, no. 2, Feb. 2009, https://doi.org/10.1590/s0100-72032009000200002. Acesso em: novembro de 2023.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Carlos Henrique Melato Gois de Britto, Fábio Siqueira, Elisa Cançado Porto Mascarenhas

This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que atribuam crédito à revista pela criação original.









